Report Overview

The Middle East & Africa diabetes care devices market was valued at US$ 679.4 million in 2021 and is expected to witness a CAGR of 7.9 % during the forecast period.

Market Fundamentals

Diabetes is a chronic disease due to high blood glucose levels in the body. The condition is commonly known as hyperglycemia, a severe condition damaging the overall system. Measuring blood glucose levels frequently and delivering insulin is necessary for this condition, achieved by diabetes care devices such as glucose monitoring devices and insulin delivery devices. These devices can give patients and physicians vital information in managing the disease.   

Market Dynamics

The global diabetes care devices market is driven by the alarming increase in diabetes cases in the Middle East & Africa region, mainly due to obesity and lifestyle changes. The government authorities in this region are focusing on increasing awareness about disease management, and healthcare practices are influencing the market growth. Furthermore, introducing products with innovative features and technologies is boosting the market in this region. However, the lack of reimbursement in this region may impede the growth of the diabetes care devices market. 

Market Ecosystem

The Middle East & Africa diabetes care devices market has been analyzed from three perspectives: types, end-users, and countries.  

Diabetes Care Devices Market by Types

[65754345]

According to types, the the Middle East & Africa diabetes care devices market is grouped into insulin delivery devices, self-blood glucose monitors, and continuous glucose monitoring devices. The insulin delivery devices segment is further classified into pen needles, syringes, and pumps. The self-blood glucose monitors category is sub-segmented into blood glucose meters/glucometers, lancets and lancing devices, and testing strips. Similarly, continuous glucose monitoring devices are again divided into receivers, sensors, and transmitters. The insulin delivery devices segment holds the majority of the market share. In recent years, the prevalence of diabetes has alarmingly increased in the Middle East and Africa. Obesity, a poor diet, and lack of exercise are the primary causes of the rise in Type 1 and Type 2 diabetes cases.

Furthermore, technological advancements offer more safe and more accurate insulin administration. For instance, In July 2021, Medtronic introduced the Extended infusion set, which uses cutting-edge materials to preserve insulin flow and stability while reducing preservative loss. The infusion set consists of a tube that transports insulin from the pump to the body and must be changed every two to three days. 

Diabetes Care Devices Market by End User 

According to end users, the Middle East & Africa diabetes care devices market is segmented into home care, diabetes specialty centers, hospitals & clinics, and others (ambulatory centers, emergency care, and diagnostics centers). The home care segment currently dominates the diabetes care devices market in the Middle East & Africa region. Factors influencing the growth are increased awareness and products offering high feasibility.

 Diabetes Care Devices Market by Region 

By country, the diabetes care devices markethas been segmented into Saudi Arabia, Turkey, South Africa, and the Rest of Middle East & Africa. South Africa has dominated the market. The growth is attributed to increased obesity cases, eventually leading to diabetes. In South Africa, diabetes is becoming more common among people of all ages, which may be attributed to an increase in a poor diet and a sedentary lifestyle. Saudi Arabia is expected to witness high growth is the forecast period. The development is owing to factors such as the increased prevalence of diabetes, increased adoption of products with high technological advancements, and high awareness and adoption of self-monitoring glucose devices is expanding in Saudi Arabia. Furthermore, increased government support in managing the disease boosts market potential. For instance, in September 2021, the Saudi Ministry of Health and the Saudi Endocrine Society announced that they intend to mandate continuous glucose monitoring devices and insulin pump devices training programs for every hospital institution and to increase the number of physicians and trainers by the end of the year.

Competitive Landscape

Some prominent players operating in the MEA diabetes care devices market are

• Abbott Laboratories Inc. 
• F. Hoffman-La Roche Ltd. 
• Novo Nordisk A/S 
• Becton, Dickinson & Company (Embecta Corp.) 
• Terumo Corporation 
• B. Braun Melsungen AG 
• Medtronic plc
• Eli Lilly and Company
• Tandem Diabetes Care, Inc. 
• Dexcom, Inc. 

Frequently Asked Questions About This Report